Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Friday, February 6, 2015

Georgia refuses Hep-C cure for poz guys

News in gay Atlanta of a drug that can eradicate previously incurable Hepatitis-C in 99 percent of cases was tainted last week by the state picking and choosing who can get it, excluding thousands of HIV-positive patients. It’s renewed a clarion call by activists to expand Medicaid.

The 12-week drug regimen known as V-Pak works, but it’s expensive – as much as $80,000 per patient. The National Alliance of State and Territorial AIDS Directors, which includes Georgia, negotiated a discount to about half price, but each state must decide whether or not to offer it under various programs.

In Georgia, that meant Hepatitis C patients under Medicaid will get V-Pak. But HIV-positive people with Hep C on ADAP, the HIV prescription assistance program, can’t. State agencies say they’re hamstrung by the cost to offer life-saving treatment to some and deny it to others, according to WABE.

Read more...

No comments:

Post a Comment